Alon Medtech Ventures
VC Fund
Yoqne`am `illit, Israel
Alon Medtech Ventures is a VC fund in Yoqne`am `illit focused on Medical and Health Care. Alon MedTech Ventures is active in the initiation and growth of young high-tech companies in the medical device arena. They seek to make a difference: Alon MedTech is engaged with novel technologies that improve human well-being and quality of life.Owned by leading Israeli Entrepreneur Dr Shimon Eckhouse, Alon MedTech is backed by a powerfullegacy. Dr Eckhouse has founded and invested in numerous medical technology firms, two of which are leading international companies, (ESC Medical [Lumenis] and Syneron Medical), both traded on NASDAQ.Their experience, professionalism, wide network and solid financial resources enable them to provide their companies with distinctive sponsorship. This includes such key factors as technological and managerial guidance, strategic counseling and fundraising.The objective of this private incubator is to accompany young ventures through all stages, from lab to marketplace – and beyond. From conceptualization of product through to company success, their assistance can extend for years after a company is up and running.Alon MedTech couples the highest levels of technological knowhow with long years of business acumen. The result: a rich and fertile environment for growing successful companies.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Alon Medtech Ventures invests in
Stages Alon Medtech Ventures invests in
Countries Alon Medtech Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $900k–$2.2M
Investment Focus
Industry
- Medical 5 (100%)
- Health Care 5 (100%)
- Medical Device 3 (60%)
- Men's 1 (20%)
- Therapeutics 1 (20%)
Stage
- Seed 2 (40%)
- Series B 1 (20%)
- Corporate Round 1 (20%)
- Venture - Series Unknown 1 (20%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Assaf Mansour
VP,Business Development
|
VP,Business Development | Total investments: 0 | Find email | |
| CEO | Total investments: 0 | Find email | ||
| CFO | Total investments: 0 | Find email | ||
Shimon Eckhouse
Founder, Owner and Chairman
|
Founder, Owner and Chairman | Total investments: 5 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Levron Medical develops a novel autonomic integrated diagnostic and therapeutic device used to treat heart failure patients. | $2.2M / Seed / Nov 24, 2025 | ||
| Serenno Medical is a medical device company creating a urine-output measuring device for the ICU. The company is the developer of a bedside urine output measuring device for hospitalized patients, offering accurate and automatic measurements with low costs, less workload, and improved patient safety.Serenno Medical was founded in 2017 and isheadquartered in Yokne'am Illit, Israel. | $1.5M / Corporate Round / Jan 20, 2021 | ||
| Anchora Medical focuses in simplifying of suturing in endoscopic and open surgery applications. The company develops a unique, single-use automatic suturing device for minimal invasive surgery. | $4.5M / Series B / Feb 26, 2020 | ||
| Filterlex Medical Ltd. is a medical device startup in the cardiovascular field. Its goal is to develop the next generation embolic protection device for reducing the risk of stroke and other complications during catheter-based structural heart procedures. The device concept and unique structure was created out of deep understanding and knowledgeof the unmet need and current products limitations and weaknesses. Filterlex is currently seeking seed funding. | $900K / Seed / Jun 01, 2016 | ||
| Butterfly Medical is a medical-device start-up that aims to improve the standard of care for men suffering from Benign Prostate Hyperplasia (BPH) or enlarged prostate. The company has developed a fast, simple and minimally invasive alternative treatment to first-line BPH medication and surgery. Butterfly Medical’s patented device can beplaced in under 10 minutes, in-office, under local anesthesia, without surgical incision, heating or prostate tissue removal. The device aims to be the only in-office BPH treatment that delivers a long-term, effective solution with minimal side effects, requiring no hospitalization or general anesthesia. Early results from clinical trials are very promising with blocked urethras successfully opened and patients suffering no side effects. Further clinical studies are starting in leading medical centers in Europe.Visit www.butterfly-medical.com for more information. | Venture - Series Unknown / Apr 01, 2016 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Alon Medtech Ventures invest in?
Alon Medtech Ventures invests primarily in Medical, Health Care and Medical Device startups, most often at Seed and Series B stage. Most of the 5 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Alon Medtech Ventures's check size?
Alon Medtech Ventures typically joins rounds of $900k–$2.2M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Alon Medtech Ventures participates in.
How do I contact Alon Medtech Ventures?
Public channels for Alon Medtech Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Alon Medtech Ventures?
The team at Alon Medtech Ventures includes Assaf Mansour (VP,Business Development), Judith Zilberstein (CEO) and MICHAEL(MIKI) EDEN (CFO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
